dobutamine has been researched along with dermatan sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Piepenbrock, S; Rahe-Meyer, N; Raymondos, K; Weilbach, C | 1 |
1 review(s) available for dobutamine and dermatan sulfate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for dobutamine and dermatan sulfate
| Article | Year |
|---|---|
Delivery of a healthy child 30 weeks after resuscitation for thromboembolism and treatment with danaparoid: 5-year follow up.
Topics: Anticoagulants; Cardiotonic Agents; Child Development; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Dobutamine; Factor V; Female; Follow-Up Studies; Genetic Predisposition to Disease; Gestational Age; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Mutation; Norepinephrine; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Respiration, Artificial; Vasoconstrictor Agents | 2006 |